Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's patients.

The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...

Kefir, a fermented milk product filled with various probiotics, is credited with aiding blood sugar regulation, cholesterol ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now caught ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains<a class="excerpt-read-more" href=" More ...